5000 a thrombolytic injection usually mainly refers to rt-PA, at present the clinical commonly used alteplase, the use of drugs need to be under the guidance of a professional doctor.
The main function of thrombolytic needle is to dissolve blood clots, usually given to patients in the acute phase of thrombolytic needle treatment, for ischemic cerebrovascular disease, thrombolytic needle is the most active treatment to try to save the patient neurological deficits, the patient’s prognosis has been significantly improved. For acute ST-segment elevation myocardial infarction, thrombolysis is also an active treatment option if intervention cannot be performed as soon as possible.
However, thrombolytic injection may also lead to potential bleeding risk, its adverse reactions mainly include subcutaneous bleeding, visceral or craniocerebral hemorrhage, etc., and its contraindications mainly include allergy to thrombolytic drugs, active ulcers, brain hemorrhage or brain tumors that have occurred within six months.
The specific use of drugs need to follow the doctor’s instructions.